Abstract
We identified a novel neuraminidase (NA)-deficient virus that was a 2009 pandemic influenza H1N1 virus mutant. The mutant virus had a deletion of 1,009 nt in the NA gene and lacked an enzymatic domain. Although the yield of the NA-deficient virus was limited, it formed large plaques when applied to MDCK cell cultures, indicating that the virus was able to spread to adjacent cells. Furthermore, the NA-deficient virus was eluted from chicken erythrocytes at 37 °C, even in the presence of the antiviral drug peramivir. Spread of this NA-deficient virus may pose a potential threat to anti-influenza therapies.
Avoid common mistakes on your manuscript.
Influenza A viruses commonly infect a large variety of hosts, including humans, pigs, horses and birds. Two of the eight RNA segments of the genome encode the surface glycoproteins hemagglutinin (HA) and neuraminidase (NA), which have 16 and 9 subtypes, respectively [2]. The HA protein is involved in virus attachment to cell-surface receptors and mediates entry of the virus into the cell by membrane fusion. The NA protein is required to release progeny virions and to prevent them from aggregating. This enzyme removes terminal sialic acids from oligosaccharide side chains, where HA binds [3].
The pandemic influenza A (H1N1) virus [A(H1N1)pdm09], containing a combination of swine, avian and human virus gene segments, emerged in humans in Mexico City in March 2009 and quickly spread worldwide [1, 17]. To date, only a small number of oseltamivir-resistant A(H1N1)pdm09 strains containing a single amino acid change (His to Tyr) at position 275 within NA (H275Y) have been detected [13] and reported among seasonal H1N1 viruses worldwide since the 2007–2008 influenza season [20]. In Japan, a surveillance study conducted during the 2008–2009 influenza season showed that oseltamivir resistance was evident in 99.7 % of H1N1 virus isolates [18].
We previously showed that the HA genes of 70 A(H1N1)pdm09 strains isolated from a single student population in 2009 in Tobetsu, Hokkaido, clustered into three groups [7]. Of these isolates, two strains exhibited lower sensitivity to oseltamivir than other strains. Morlighem et al. conducted a phylogenetic analysis of 253 samples based on the NA gene of Japanese A(H1N1)pdm09. They identified an N248D mutation in NA, which allowed discrimination of isolates between the early (May 2009) and peak (October 2009 to January 2010) phases of infection [13]. In the present study, we describe for the first time the isolation of an NA-deficient mutant of A(H1N1)pdm09, and its subsequent characterization.
One of the two isolates with low sensitivity to oseltamivir, A/Hokkaido/T64/2009 (H1N1) (T64), was found to form plaques of various sizes on Madin-Darby canine kidney (MDCK) cells, indicating that it was composed of a mixed population of virions. We analyzed several plaques and successfully obtained an NA-deficient mutant, designated T64LP4, which formed large uniform-sized plaques (Fig. 1A). A full-genome amplification technique [8] demonstrated that T64LP4 lacked the NA gene (Fig. 1B). The amplification products included a prominent extra band that migrated faster than that of the NS gene. The nucleotide sequence of the 0.5-kb band coincided with 166 nt at the 5′-terminus and 235 nt at the 3′-terminus of the NA gene for the parental strain T64 (DDBJ Accession Nos. AB847956 and AB847955). Phylogenetic analysis of the gene indicated that T64LP4 was derived from the parental virus (data not shown). The 1,009-nt deletion generated an open reading frame (ORF) encoding a protein of 57 amino acids (aa), with 55 aa corresponding to the N-terminus of NA (Fig. 1C). The mutant NA comprised the transmembrane and 20-aa stalk regions, along with an additional 2 aa (Leu and Ser). The mutant NA lacked an enzymatic globular head domain. We also observed two aa changes in the mutant T64 NA (D199N and D416N), based on A/Sapporo/1/2009 (H1N1) (Sapporo), which was the first A(H1N1)pdm09 isolated in Hokkaido.
Growth kinetics in MDCK cells were compared between the parent T64 and mutant T64LP4 strains. The growth rate of T64LP4 was slower than that for T64 (Fig. 2), and the yield of T64LP4 was 1,000-fold lower than that of T64 at 32 h postinfection. After 32 h postinfection, Clostridium perfringens sialidase was added to the culture medium of T64- and T64LP4-infected cells. Although the enzyme had no effect on T64 titer, the T64LP4 titer increased more than 40-fold 2 h after sialidase was added. This finding indicated that the low yield of T64LP4 was partially due to a lack of NA activity.
Elution of T64 and T64LP4 virions from chicken erythrocytes was compared. Both types were eluted from erythrocytes after a 6-h incubation at 37 °C, although T64LP4 lacked the NA enzymatic domain (Fig. 3). Peramivir inhibited elution of T64 and A/Denmark/524/2009 (H1N1) (Den/524). No inhibition was observed for T64LP4 or A/Denmark/527/2009 (H1N1) (Den/H275Y), which contained the H275Y mutation.
An optimal balance between receptor binding and receptor destruction by HA and NA respectively, is important for viral replication in cultured cells and experimental animals [5, 11, 15, 16, 19, 24]. Mismatched pairs of HA and NA can be rescued by adaptive mutations in one or both proteins after several cycles of infection in cell culture [4, 9, 10]. Oseltamivir-resistant viruses with the H275Y mutation exhibited decreased ratios of NA:HA activities compared with drug-sensitive viruses [23]. For T64 and T64LP4, two aa substitutions (K153E and M257I) were observed in HA (DDBJ accession Nos. AB665976 and AB847957). At positions 153-157, there is a prominent loop to the left of the receptor-binding site [22]. Substitution from a positively charged Lys to a negatively charged Glu affects the affinity for the negatively charged sialic acid moiety. It is therefore possible that T64LP4 has reduced receptor-binding affinity, thereby enabling it to be eluted from erythrocytes despite the fact that it lacks NA.
Peramivir treatment resulted in no observable effects on the growth of T64LP4- or Den/H275Y (data not shown). The S247N mutation of NA resulted in a moderate reduction to oseltamivir and zanamivir sensitivity, as has also been observed in A(H1N1)pdm09 isolates [6]. When the H275Y mutation is combined with the S247N mutation, the virus becomes highly resistant to oseltamivir. Although the yield of T64LP4 was decreased by approximately 1,000-fold compared with the parental strain, it formed large plaques on MDCK cells. This finding indicates that NA is not essential for cell-to-cell infection. Mori et al. reported that influenza viruses can spread in an NA-independent manner to adjacent cells [12]. Furthermore, bacterial sialidase can improve the yield of T64LP4. Upper respiratory tract bacteria such as Streptococcus pneumoniae release sialidase, and even human saliva contains sialidase [14]. It is therefore postulated that T64LP4 can efficiently replicate in the upper respiratory tract of humans. Such an NA-deficient influenza virus will more than likely be resistant to all NA inhibitors and pose a potential threat to anti-influenza therapies. To control influenza epidemics, surveillance and extensive studies on NA-deficient clinical isolates are urgently required.
References
Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360:2605–2615
Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, Smith D, Rimmelzwaan GF, Olsen B, Osterhaus AD (2005) Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79:2814–2822
Gamblin SJ, Skehel JJ (2010) Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem 285:28403–28409
Hughes MT, Matrosovich M, Rodgers ME, McGregor M, Kawaoka Y (2000) Influenza A viruses lacking sialidase activity can undergo multiple cycles of replication in cell culture, eggs, or mice. J Virol 74:5206–5212
Hughes MT, McGregor M, Suzuki T, Suzuki Y, Kawaoka Y (2001) Adaptation of influenza A viruses to cells expressing low levels of sialic acid leads to loss of neuraminidase activity. J Virol 75:3766–3770
Hurt AC, Lee RT, Leang SK, Cui L, Deng YM, Phuah SP, Caldwell N, Freeman K, Komadina N, Smith D, Speers D, Kelso A, Lin RT, Maurer-Stroh S, Barr IG (2011) Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation. Euro Surveill 16 pii: 19884
Inoue E, Ieko M, Takahashi N, Osawa Y, Okazaki K (2012) Phylogenetic analyses of pandemic influenza A (H1N1) virus in university students at Tobetsu, Hokkaido, Japan. Microbiol Immunol 56:273–279
Inoue E, Wang X, Osawa Y, Okazaki K (2010) Full genomic amplification and subtyping of influenza A virus using a single set of universal primers. Microbiol Immunol 54:129–134
Kaverin NV, Gambaryan AS, Bovin NV, Rudneva IA, Shilov AA, Khodova OM, Varich NL, Sinitsin BV, Makarova NV, Kropotkina EA (1998) Post-reassortment changes in influenza A virus hemagglutinin restoring HA-NA functional match. Virology 244:315–321
Kaverin NV, Matrosovich MN, Gambaryan AS, Rudneva IA, Shilov AA, Varich NL, Makarova NV, Kropotkina EA, Sinitsin BV (2000) Intergenic HA-NA interactions in influenza A virus: post-reassortment substitutions of charged amino acid in the hemagglutinin of different subtypes. Virus Res 66:123–129
Mitnaul LJ, Matrosovich M, Castrucci MR, Tuzikov AB, Bovin NV, Kobasa D, Kawaoka Y (2000) Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol 74:6015–6020
Mori K, Haruyama T, Nagata K (2011) Tamiflu-resistant but HA-mediated cell-to-cell transmission through apical membranes of cell-associated influenza viruses. PLos One 6:e28178
Morlighem JÉ, Aoki S, Kishima M, Hanami M, Ogawa C, Jalloh A, Takahashi Y, Kawai Y, Saga S, Hayashi E, Ban T, Izumi S, Wada A, Mano M, Fukunaga M, Kijima Y, Shiomi M, Inoue K, Hata T, Koretsune Y, Kudo K, Himeno Y, Hirai A, Takahashi K, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Kawaoka Y, Hayashizaki Y, Ishikawa T (2011) Mutation analysis of 2009 pandemic influenza A(H1N1) viruses collected in Japan during the peak phase of the pandemic. PLoS One 6:e18956
Nishikawa T, Shimizu K, Tanaka T, Kuroda K, Takayama T, Yamamoto T, Hanada N, Hamada Y (2012) Bacterial neuraminidase rescues influenza virus replication from inhibition by a neuraminidase inhibitor. PLoS One 7:e45371
Rudneva IA, Kovaleva VP, Varich NL, Farashyan VR, Gubareva LV, Yamnikova SS, Popova IA, Presnova VP, Kaverin NV (1993) Influenza A virus reassortants with surface glycoprotein genes of the avian parent viruses: effects of HA and NA gene combinations on virus aggregation. Arch Virol 133:437–450
Rudneva IA, Sklyanskaya EI, Barulina OS, Yamnikova SS, Kovaleva VP, Tsvetkova IV, Kaverin NV (1996) Phenotypic expression of HA-NA combinations in human-avian influenza A virus reassortants. Arch Virol 141:1091–1099
Schnitzler SU, Schnitzler P (2009) An update on swine-origin influenza virus A/H1N1: a review. Virus Genes 39:279–292
Ujike M, Shimabukuro K, Mochizuki K, Obuchi M, Kageyama T, Shirakura M, Kishida N, Yamashita K, Horikawa H, Kato Y, Fujita N, Tashiro M, Odagiri T, Working Group for Influenza Virus Surveillance in Japan (2010) Oseltamivir-resistant influenza viruses A (H1N1) during 2007–2009 influenza seasons, Japan. Emerg Infect Dis 16:926–935
Wagner R, Matrosovich M, Klenk HD (2002) Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev Med Virol 12:159–166
World Health Organization (2008) Influenza A(H1N1) virus resistance to oseltamivir. http://www.who.int/influenza/patient_care/antivirals/oseltamivir_summary/en/
World Health Organization (2011) Manual for the laboratory diagnosis and virological surveillance of influenza
Yang H, Carney P, Stevens J (2010) Structure and Receptor binding properties of a pandemic H1N1 virus hemagglutinin. PLoS Curr 2:RRN1152
Yang JR, Huang YP, Chang FY, Hsu LC, Huang HY, Pan YT, Lin YC, Wu HS, Liu MT (2013) Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009–2011. J Med Virol 85:379–387
Yen HL, Liang CH, Wu CY, Forrest HL, Ferguson A, Choy KT, Jones J, Wong DD, Cheung PP, Hsu CH, Li OT, Yuen KM, Chan RW, Poon LL, Chan MC, Nicholls JM, Krauss S, Wong CH, Guan Y, Webster RG, Webby RJ, Peiris M (2011) Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1 influenza virus in ferrets. Proc Natl Acad Sci USA 108:14264–14269
Acknowledgments
This work was supported in part by a grant from the Ministry of Health, Labour and Welfare of Japan. We thank Dr. Odagiri of the National Institute of Infectious Diseases, Japan, for providing A/Denmark/524/2009 (H1N1) and A/Denmark/527/2009 (H1N1).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Inoue, E., Ieko, M., Takahashi, N. et al. An NA-deficient 2009 pandemic H1N1 influenza virus mutant can efficiently replicate in cultured cells. Arch Virol 159, 797–800 (2014). https://doi.org/10.1007/s00705-013-1887-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-013-1887-0